S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Deep Track Capital/Q2 2026

Deep Track Capital

Periodo: Q2 2026 · Depositato: 2026-08-14
Vedi su SEC EDGAR
AUM
$6.87B
Valore totale del portafoglio
Posizioni
67
Titoli dichiarati
Prima Posizione
GH
7.4% $509.1M
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2026-08-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
GHGUARDANT HEALTH INC$509.1M7.41%$150.03$157.21+4.8%
7.4%
IMVTIMMUNOVANT INC$359.9M5.24%$38.53$41.82+8.5%
5.2%
GPCRSTRUCTURE THERAPEUTICS INC$254.4M3.70%$53.67$54.51+1.6%
3.7%
PCVXVAXCYTE INC$250.0M3.64%$58.13$58.07-0.1%
3.6%
ALNYALNYLAM PHARMACEUTICALS INC$248.3M3.61%$301.03$228.65-24.0%
3.6%
MANEVERADERMICS INC$245.9M3.58%$122.94$112.71-8.3%
3.6%
TARSTARSUS PHARMACEUTICALS INC$230.8M3.36%$62.94$69.20+9.9%
3.4%
NUVLNUVALENT INC$220.2M3.21%
3.2%
ALKSALKERMES PLC$209.6M3.05%$52.40$49.06-6.4%
3.0%
OCULOCULAR THERAPEUTIX INC$193.3M2.81%$9.82$10.04+2.2%
2.8%
BMRNBIOMARIN PHARMACEUTICAL INC$189.3M2.75%$57.22$67.36+17.7%
2.8%
NRIXNURIX THERAPEUTICS INC$187.7M2.73%$24.26$27.05+11.5%
2.7%
ORKAORUKA THERAPEUTICS INC$183.3M2.67%$95.17$111.04+16.7%
2.7%
ALMSALUMIS INC$178.7M2.60%$28.14$25.31-10.1%
2.6%
IONSIONIS PHARMACEUTICALS INC$174.4M2.54%$79.29$57.24-27.8%
2.5%
CMPSCOMPASS PATHWAYS PLC$172.1M2.50%$14.15$13.45-5.0%
2.5%
VERAVERA THERAPEUTICS INC$171.6M2.50%$42.91$31.63-26.3%
2.5%
AXSMAXSOME THERAPEUTICS INC.$171.3M2.49%$244.77$213.67-12.7%
2.5%
GMABGENMAB A/S$155.2M2.26%$27.47$31.94+16.3%
2.3%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$136.3M1.98%$19.47$16.47-15.4%
2.0%
COAGHEMAB THERAPEUTICS HLDGS INC$132.3M1.93%$36.73$54.94+49.6%
1.9%
TNGXTANGO THERAPEUTICS INC$131.3M1.91%$31.26$25.60-18.1%
1.9%
DFTXDEFINIUM THERAPEUTICS INC$129.4M1.88%$47.04$42.63-9.4%
1.9%
GRALGRAIL INC$125.3M1.82%$68.27$67.87-0.6%
1.8%
BCAXBICARA THERAPEUTICS INC$121.7M1.77%$29.69$24.28-18.2%
1.8%
MAZEMAZE THERAPEUTICS INC$111.4M1.62%$29.84$27.18-8.9%
1.6%
CLDXCELLDEX THERAPEUTICS INC NEW$109.4M1.59%$37.21$41.95+12.7%
1.6%
LBRXLB PHARMACEUTICALS INC$108.8M1.58%$32.46$47.78+47.2%
1.6%
MBXMBX BIOSCIENCES INC$95.6M1.39%$55.20$68.57+24.2%
1.4%
GHRSGH RESEARCH PLC$89.6M1.30%$26.88$29.49+9.7%
1.3%

Attività Trimestre su Trimestre

Q2 2026 vs. Q1 2026

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
ALNYALNYLAM PHARMACEUTICALS INC$248.3M-24.0%
COAGHEMAB THERAPEUTICS HLDGS INC$132.3M+49.6%
GHRSGH RESEARCH PLC$89.6M+9.7%
UTHRUNITED THERAPEUTICS CORP DEL$67.0M
AVTXAVALO THERAPEUTICS INC$66.7M
ALTALTIMMUNE INC$58.5M
WGSGENEDX HOLDINGS CORP$48.1M
HROWHARROW INC$41.1M

Posizioni Chiuse (8)

TickerEmittenteNozionale
XBISPDR SERIES TRUST$1.28B
APLSAPELLIS PHARMACEUTICALS INC$182.3M
CNTACENTESSA PHARMACEUTICALS PLC$125.4M
BBIOBRIDGEBIO PHARMA INC$62.5M
TERNTERNS PHARMACEUTICALS INC$56.6M
GERNGERON CORP$47.3M
ANIPANI PHARMACEUTICALS INC$46.1M
SLNOSOLENO THERAPEUTICS INC$36.1M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
MANEVERADERMICS INC$214.3M+300.0%-8.3%
BMRNBIOMARIN PHARMACEUTICAL INC$124.3M+187.6%+17.7%
VRDNVIRIDIAN THERAPEUTICS INC$38.7M+157.7%
CLDXCELLDEX THERAPEUTICS INC NEW$68.6M+128.9%+12.7%
COGTCOGENT BIOSCIENCES INC$38.9M+100.0%
GMABCALLGENMAB A/S$56.9M+54.2%+16.3%
TNGXTANGO THERAPEUTICS INC$73.8M+52.7%-18.1%
PSNLPERSONALIS INC$34.5M+33.3%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
IMCRIMMUNOCORE HLDGS PLC$-48.4M-83.9%
CYTKCYTOKINETICS INC$-30.9M-49.1%
MBXMBX BIOSCIENCES INC$13.3M-37.2%+24.2%
AXSMAXSOME THERAPEUTICS INC.$-14.6M-36.4%-12.7%
IVAINVENTIVA SA$-3.8M-34.6%
ENTAENANTA PHARMACEUTICALS INC$-3.7M-26.2%
KURAKURA ONCOLOGY INC$0.2M-25.2%
DYNDYNE THERAPEUTICS INC$-2.9M-25.0%
Torna agli Hedge Fund